Sanjeev Kumar

Sanjeev Kumar serves as Vice President and Head of Global Drug Metabolism, Pharmacokinetics and Bioanalysis at Vertex Pharmaceuticals since May 2012, where additional roles include membership on the Corporate Disease Strategy Team for Alpha1 Antitrypsin Deficiency. Concurrently, Sanjeev contributes to the Bill & Melinda Gates Foundation as a member of the Expert Advisory Group for the TB Drug Accelerator since April 2023. Sanjeev's prior experience includes over 13 years at Merck, holding positions from Senior Research Chemist to Director in Drug Metabolism and Pharmacokinetics. Educational credentials include a PhD in Pharmaceutical Sciences from The University of British Columbia and both a B. Pharm and M. Pharm in Pharmaceutical Sciences from Panjab University.